Targeting ORM1-CCR5 axis inhibits the aggressive phenotype of synovial fibroblasts and alleviates RA

Open Medicine · Published 2026-01-01 · DOI 10.1515/med-2025-1365

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.1515/med-2025-1365

Abstract

The present study focused on exploring the role of orosomucoid 1 (ORM1) in rheumatoid arthritis (RA).

Abstract from DOAJ. Public domain (CC0 1.0).

Read the article at the publisher →

Publication details

Year

2026

Related articles

• Epidemiological trends, antimicrobial resistance, and genetic mutations of Mycoplasma pneumoniae in Wuhan, China: a post-COVID-19 perspective · Open Medicine · 2026 · Same journal
• Effect of adalimumab on anxiety-depression-like behaviors and learning in rats receiving cisplatin · Open Medicine · 2026 · Same journal
• Bochdalek hernia in pregnancy complicated with eclampsia: a case report · Open Medicine · 2026 · Same journal
• Identification of age-specific urinary metabolic biomarkers in Wilson disease using machine learning: a comparative study of ensemble tree models · Open Medicine · 2026 · Same journal
• Correlation analysis of coagulation factor level and chronic low-grade inflammation in patients with type 2 diabetes mellitus complicated with ischemic stroke · Open Medicine · 2026 · Same journal
• Discovery and validation of key genes and potential mechanisms linked to endothelial cell senescence and carbohydrate metabolism in recurrent spontaneous abortion · Open Medicine · 2026 · Same journal
• Survival benefits of immunotherapy combined with chemoradiotherapy in metastatic colorectal cancer: an analysis based on data from the SEER database · Open Medicine · 2026 · Same journal
• Right coronary artery originated from left coronary sinus associated with children hypertrophic cardiomyopathy: report of two cases and literature review · Open Medicine · 2026 · Same journal
• A case report of sanguisis streptococcal sepsis associated with the orthodontic appliance in a young male with aortic valve disease · Open Medicine · 2026 · Same journal
• Computational design of a multiepitope vaccine targeting VP1 and VP2 capsid proteins of simian virus 40 (SV40) for enhanced immune activation · Open Medicine · 2026 · Same journal